{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:28:43Z","timestamp":1794007723673,"version":"4.8.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T00:00:00Z","timestamp":1715126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T00:00:00Z","timestamp":1715126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009891","name":"International Society of Nephrology","doi-asserted-by":"publisher","award":["Grant RES0033080"],"award-info":[{"award-number":["Grant RES0033080"]}],"id":[{"id":"10.13039\/100009891","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>There is a lack of contemporary data describing global variations in vascular access for hemodialysis (HD). We used the third iteration of the International Society of Nephrology Global Kidney Health Atlas (ISN-GKHA) to highlight differences in funding and availability of hemodialysis accesses used for initiating HD across world regions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Survey questions were directed at understanding the funding modules for obtaining vascular access and types of accesses used to initiate dialysis. An electronic survey was sent to national and regional key stakeholders affiliated with the ISN between June and September 2022. Countries that participated in the survey were categorized based on World Bank Income Classification (low-, lower-middle, upper-middle, and high-income) and by their regional affiliation with the ISN.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Data on types of vascular access were available from 160 countries. Respondents from 35 countries (22% of surveyed countries) reported that &gt;\u200950% of patients started HD with an arteriovenous fistula or graft (AVF or AVG). These rates were higher in Western Europe (<jats:italic>n<\/jats:italic>\u2009=\u200914; 64%), North &amp; East Asia (<jats:italic>n<\/jats:italic>\u2009=\u20094; 67%), and among high-income countries (<jats:italic>n<\/jats:italic>\u2009=\u200924; 38%). The rates of &gt;\u200950% of patients starting HD with a tunneled dialysis catheter were highest in North America &amp; Caribbean region (<jats:italic>n<\/jats:italic>\u2009=\u20097; 58%) and lowest in South Asia and Newly Independent States and Russia (<jats:italic>n<\/jats:italic>\u2009=\u20090 in both regions). Respondents from 50% (<jats:italic>n<\/jats:italic>\u2009=\u20099) of low-income countries reported that &gt;\u200975% of patients started HD using a temporary catheter, with the highest rates in Africa (<jats:italic>n<\/jats:italic>\u2009=\u200930; 75%) and Latin America (<jats:italic>n<\/jats:italic>\u2009=\u200914; 67%). Funding for the creation of vascular access was often through public funding and free at the point of delivery in high-income countries (<jats:italic>n<\/jats:italic>\u2009=\u200942; 67% for AVF\/AVG, <jats:italic>n<\/jats:italic>\u2009=\u200944; 70% for central venous catheters). In low-income countries, private and out of pocket funding was reported as being more common (<jats:italic>n<\/jats:italic>\u2009=\u20098; 40% for AVF\/AVG, <jats:italic>n<\/jats:italic>\u2009=\u20095; 25% for central venous catheters).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>High income countries exhibit variation in the use of AVF\/AVG and tunneled catheters. In low-income countries, there is a higher use of temporary dialysis catheters and private funding models for access creation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-024-03593-z","type":"journal-article","created":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T16:02:27Z","timestamp":1715184147000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Global variations in funding and use of hemodialysis accesses: an international report using the ISN Global Kidney Health Atlas"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9165-4920","authenticated-orcid":false,"given":"Anukul","family":"Ghimire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samveg","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Utkarsh","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwaifa Salihu","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailash","family":"Jindal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumeyza","family":"Kazancioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie A.","family":"Luyckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"MacRae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy O.","family":"Olanrewaju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert R.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Ravani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somkanya","family":"Tungsanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushar","family":"Vachharanjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Arruebo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fergus J.","family":"Caskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Damster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo-Ann","family":"Donner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivekanand","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeera","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charu","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaomi","family":"Nangaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Tonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikechi G.","family":"Okpechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aminu K.","family":"Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,8]]},"reference":[{"issue":"3","key":"3593_CR1","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1681\/ASN.2012070643","volume":"24","author":"P Ravani","year":"2013","unstructured":"Ravani P, Palmer SC, Oliver MJ, Quinn RR, MacRae JM, Tai DJ, et al. Associations between hemodialysis access type and clinical outcomes: a systematic review. J Am Soc Nephrol. 2013;24(3):465\u201373.","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"3593_CR2","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1093\/ndt\/gfn261","volume":"23","author":"J Ethier","year":"2008","unstructured":"Ethier J, Mendelssohn DC, Elder SJ, Hasegawa T, Akizawa T, Akiba T, et al. Vascular access use and outcomes: an international perspective from the Dialysis outcomes and practice patterns study. Nephrol Dial Transpl. 2008;23(10):3219\u201326.","journal-title":"Nephrol Dial Transpl"},{"issue":"4","key":"3593_CR3","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1053\/j.ajkd.2019.12.001","volume":"75","author":"CE Lok","year":"2020","unstructured":"Lok CE, Huber TS, Lee T, Shenoy S, Yevzlin AS, Abreo K, et al. KDOQI Clinical Practice Guideline for Vascular Access: 2019 update. Am J Kidney Dis. 2020;75(4):S1\u2013164.","journal-title":"Am J Kidney Dis"},{"key":"3593_CR4","doi-asserted-by":"crossref","unstructured":"Chan CT, Blankestijn PJ, Dember LM, Gallieni M, Harris DCH, Lok CE et al. Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019;96(1):37\u201347.","DOI":"10.1016\/j.kint.2019.01.017"},{"issue":"6","key":"3593_CR5","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.34067\/KID.0006622021","volume":"3","author":"IC Maguire","year":"2022","unstructured":"Maguire IC, Browne LD, Dawood M, Leahy F, Ryan MC, White E, et al. Differential Impact of Central venous catheters versus Arteriovenous Fistulae on Quality of Life among Irish Haemodialysis patients. Kidney360. 2022;3(6):1065\u201372.","journal-title":"Kidney360"},{"issue":"2","key":"3593_CR6","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1177\/112972980800900208","volume":"9","author":"RR Quinn","year":"2008","unstructured":"Quinn RR, Lamping DL, Lok CE, Meyer RA, Hiller JA, Lee J, et al. The Vascular Access Questionnaire: assessing patient-reported views of vascular access. J Vasc Access. 2008;9(2):122\u20138.","journal-title":"J Vasc Access"},{"issue":"9811","key":"3593_CR7","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0140-6736(11)60178-5","volume":"379","author":"AS Levey","year":"2012","unstructured":"Levey AS, Coresh J. Chronic kidney disease. Lancet. 2012;379(9811):165\u201380.","journal-title":"Lancet"},{"issue":"9981","key":"3593_CR8","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/S0140-6736(14)61601-9","volume":"385","author":"T Liyanage","year":"2015","unstructured":"Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975\u201382.","journal-title":"Lancet"},{"issue":"3","key":"3593_CR9","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1053\/j.ajkd.2020.05.030","volume":"77","author":"H Htay","year":"2021","unstructured":"Htay H, Bello AK, Levin A, Lunney M, Osman MA, Ye F, et al. Hemodialysis Use and practice patterns: an International Survey Study. Am J Kidney Dis. 2021;77(3):326\u2013e3351.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"3593_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.kisu.2017.08.001","volume":"7","author":"AK Bello","year":"2017","unstructured":"Bello AK, Johnson DW, Feehally J, Harris D, Jindal K, Lunney M, et al. Global Kidney Health Atlas (GKHA): design and methods. Kidney Int Suppl (2011). 2017;7(2):145\u201353.","journal-title":"Kidney Int Suppl (2011)"},{"issue":"2","key":"3593_CR11","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1016\/j.kisu.2021.01.010","volume":"11","author":"AK Bello","year":"2021","unstructured":"Bello AK, Okpechi IG, Jha V, Harris DCH, Levin A, Johnson DW. Understanding distribution and variability in care organization and services for the management of kidney care across world regions. Kidney Int Suppl (2011). 2021;11(2):e4\u201310.","journal-title":"Kidney Int Suppl (2011)"},{"key":"3593_CR12","doi-asserted-by":"crossref","unstructured":"D\u0119bska-\u015alizie\u0144 A, Bello AK, Johnson DW, Jha V, Harris DCH, Levin A et al. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Eastern and Central Europe. Kidney Int Suppl (2011). 2021;11(2):e24-e34.","DOI":"10.1016\/j.kisu.2021.01.008"},{"issue":"1","key":"3593_CR13","doi-asserted-by":"publisher","first-page":"e004014","DOI":"10.1136\/bmjgh-2020-004014","volume":"6","author":"P Riaz","year":"2021","unstructured":"Riaz P, Caskey F, McIsaac M, Davids R, Htay H, Jha V, et al. Workforce capacity for the care of patients with kidney failure across world countries and regions. BMJ Glob Health. 2021;6(1):e004014.","journal-title":"BMJ Glob Health"},{"issue":"6","key":"3593_CR14","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1097\/TP.0000000000003943","volume":"106","author":"D Mudiayi","year":"2022","unstructured":"Mudiayi D, Shojai S, Okpechi I, Christie EA, Wen K, Kamaleldin M, et al. Global Estimates of Capacity for Kidney Transplantation in World Countries and regions. Transplantation. 2022;106(6):1113\u201322.","journal-title":"Transplantation"},{"issue":"1","key":"3593_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2215\/CJN.09070620","volume":"16","author":"M Lunney","year":"2020","unstructured":"Lunney M, Bello AK, Levin A, Tam-Tham H, Thomas C, Osman MA, et al. Availability, accessibility, and quality of conservative kidney Management Worldwide. Clin J Am Soc Nephrol. 2020;16(1):79\u201387.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"3593_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1053\/j.ajkd.2020.05.032","volume":"77","author":"Y Cho","year":"2021","unstructured":"Cho Y, Bello AK, Levin A, Lunney M, Osman MA, Ye F, et al. Peritoneal Dialysis use and practice patterns: an International Survey Study. Am J Kidney Dis. 2021;77(3):315\u201325.","journal-title":"Am J Kidney Dis"},{"key":"3593_CR17","doi-asserted-by":"crossref","unstructured":"Wainstein M, Bello AK, Jha V, Harris DCH, Levin A, Gonzalez-Bedat MC et al. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Latin America. Kidney Int Suppl (2011). 2021;11(2):e35-e46.","DOI":"10.1016\/j.kisu.2021.01.005"},{"key":"3593_CR18","doi-asserted-by":"crossref","unstructured":"Bello AK, McIsaac M, Okpechi IG, Johnson DW, Jha V, Harris DCH et al. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in North America and the Caribbean. Kidney Int Suppl (2011). 2021;11(2):e66-e76.","DOI":"10.1016\/j.kisu.2021.01.001"},{"key":"3593_CR19","doi-asserted-by":"crossref","unstructured":"Oguejiofor F, Kiggundu DS, Bello AK, Swanepoel CR, Ashuntantang G, Jha V et al. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Africa. Kidney Int Suppl (2011). 2021;11(2):e11-e23.","DOI":"10.1016\/j.kisu.2021.01.009"},{"key":"3593_CR20","doi-asserted-by":"crossref","unstructured":"Kelly DM, Anders HJ, Bello AK, Choukroun G, Coppo R, Dreyer G et al. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Western Europe. Kidney Int Suppl (2011). 2021;11(2):e106-e118.","DOI":"10.1016\/j.kisu.2021.01.007"},{"issue":"1","key":"3593_CR21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.23876\/j.krcp.21.236","volume":"41","author":"J Bharati","year":"2022","unstructured":"Bharati J, Jha V. Global kidney Health Atlas: a spotlight on the Asia-Pacific sector. Kidney Res Clin Pract. 2022;41(1):22\u201330.","journal-title":"Kidney Res Clin Pract"},{"issue":"11","key":"3593_CR22","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1681\/ASN.2006030190","volume":"17","author":"CE Lok","year":"2006","unstructured":"Lok CE, Allon M, Moist L, Oliver MJ, Shah H, Zimmerman D. Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas (REDUCE FTM I). J Am Soc Nephrol. 2006;17(11):3204\u201312.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"3593_CR23","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/hdi.12503","volume":"21","author":"B Bikbov","year":"2017","unstructured":"Bikbov B, Bieber B, Andrusev A, Tomilina N, Zemchenkov A, Zhao J, et al. Hemodialysis practice patterns in the Russia Dialysis outcomes and practice patterns study (DOPPS), with international comparisons. Hemodial Int. 2017;21(3):393\u2013408.","journal-title":"Hemodial Int"},{"issue":"1","key":"3593_CR24","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/s41598-020-79531-4","volume":"11","author":"X Zhao","year":"2021","unstructured":"Zhao X, Niu Q, Gan L, Hou FF, Liang X, Ni Z, et al. Baseline data report of the China Dialysis Outcomes and practice patterns study (DOPPS). Sci Rep. 2021;11(1):873.","journal-title":"Sci Rep"},{"key":"3593_CR25","doi-asserted-by":"publisher","first-page":"205435812311541","DOI":"10.1177\/20543581231154185","volume":"10","author":"TM Kitzler","year":"2023","unstructured":"Kitzler TM, Chun J. Understanding the current Landscape of kidney disease in Canada to Advance Precision Medicine guided Personalized Care. Can J Kidney Health Dis. 2023;10:20543581231154185.","journal-title":"Can J Kidney Health Dis"},{"key":"3593_CR26","unstructured":"The DOPPS Practice Monitor. Canada: Demographics - Age, categories. https:\/\/www.dopps.org\/DPM-HD\/Canada. Accessed 05 Aug 2023."},{"issue":"6","key":"3593_CR27","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1053\/j.ajkd.2010.12.023","volume":"57","author":"M Wagner","year":"2011","unstructured":"Wagner M, Ansell D, Kent DM, Griffith JL, Naimark D, Wanner C, et al. Predicting Mortality in Incident Dialysis patients: an analysis of the United Kingdom Renal Registry. Am J Kidney Dis. 2011;57(6):894\u2013902.","journal-title":"Am J Kidney Dis"},{"key":"3593_CR28","doi-asserted-by":"publisher","first-page":"205435811875967","DOI":"10.1177\/2054358118759675","volume":"5","author":"C Dumaine","year":"2018","unstructured":"Dumaine C, Kiaii M, Miller L, Moist L, Oliver MJ, Lok CE, et al. Vascular Access practice patterns in Canada: A National Survey. Can J Kidney Health Dis. 2018;5:2054358118759675.","journal-title":"Can J Kidney Health Dis"},{"issue":"11","key":"3593_CR29","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1093\/ndt\/gfn317","volume":"23","author":"J Graham","year":"2008","unstructured":"Graham J, Hiremath S, Magner PO, Knoll GA, Burns KD. Factors influencing the prevalence of central venous catheter use in a Canadian haemodialysis centre. Nephrol Dial Transpl. 2008;23(11):3585\u201391.","journal-title":"Nephrol Dial Transpl"},{"key":"3593_CR30","unstructured":"CMS.gov. ESRD Quality Incentive Program. https:\/\/www.cms.gov\/medicare\/quality-initiatives-patient-assessment-instruments\/esrdqip. Accessed 5 Aug 2023."},{"issue":"5","key":"3593_CR31","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.2215\/CJN.01080307","volume":"2","author":"CE Lok","year":"2007","unstructured":"Lok CE. Fistula first initiative: advantages and pitfalls. Clin J Am Soc Nephrol. 2007;2(5):1043\u201353.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"3593_CR32","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1053\/j.ajkd.2014.12.014","volume":"65","author":"RL Pisoni","year":"2015","unstructured":"Pisoni RL, Zepel L, Port FK, Robinson BM. Trends in us vascular access use, patient preferences, and related practices: an update from the US DOPPS practice monitor with international comparisons. Am J Kidney Dis. 2015;65(6):905\u201315.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"3593_CR33","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.jvs.2018.01.049","volume":"68","author":"IJ Arhuidese","year":"2018","unstructured":"Arhuidese IJ, Orandi BJ, Nejim B, Malas M, Francisco S. Utilization, patency, and complications associated with vascular access for hemodialysis in the United States. J Vasc Surg. 2018;68(4):1166\u201374.","journal-title":"J Vasc Surg"},{"issue":"5","key":"3593_CR34","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1001\/jamasurg.2014.3484","volume":"150","author":"MB Malas","year":"2015","unstructured":"Malas MB, Canner JK, Hicks CW, Arhuidese IJ, Zarkowsky DS, Qazi U, et al. Trends in incident hemodialysis access and mortality. JAMA Surg. 2015;150(5):441\u20138.","journal-title":"JAMA Surg"},{"issue":"3","key":"3593_CR35","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s13239-017-0319-9","volume":"8","author":"T Lee","year":"2017","unstructured":"Lee T. Fistula First Initiative: historical impact on Vascular Access practice patterns and influence on future vascular Access Care. Cardiovasc Eng Technol. 2017;8(3):244\u201354.","journal-title":"Cardiovasc Eng Technol"},{"issue":"2","key":"3593_CR36","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1681\/ASN.2016010019","volume":"28","author":"RS Brown","year":"2017","unstructured":"Brown RS, Patibandla BK, Goldfarb-Rumyantzev AS. The survival benefit of Fistula First, Catheter Last in hemodialysis is primarily due to patient factors. J Am Soc Nephrol. 2017;28(2):645\u201352.","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"3593_CR37","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1093\/ndt\/gfy319","volume":"34","author":"C Lomonte","year":"2019","unstructured":"Lomonte C, Basile C, Mitra S, Combe C, Covic A, Davenport A, et al. Should a fistula first policy be revisited in elderly haemodialysis patients? Nephrol Dial Transpl. 2019;34(10):1636\u201343.","journal-title":"Nephrol Dial Transpl"},{"issue":"4","key":"3593_CR38","first-page":"235","volume":"7","author":"H Zhang","year":"2021","unstructured":"Zhang H, Lu H, Li W, Jiang G, Zou H. Expert consensus on the establishment and maintenance of native arteriovenous fistula. Chronic Dis Transl Med. 2021;7(4):235\u201353.","journal-title":"Chronic Dis Transl Med"},{"issue":"5","key":"3593_CR39","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/ki.2014.162","volume":"86","author":"EG Clark","year":"2014","unstructured":"Clark EG, Barsuk JH. Temporary hemodialysis catheters: recent advances. Kidney Int. 2014;86(5):888\u201395.","journal-title":"Kidney Int"},{"issue":"2","key":"3593_CR40","doi-asserted-by":"publisher","first-page":"98","DOI":"10.5830\/CVJA-2020-049","volume":"32","author":"IR Grant","year":"2021","unstructured":"Grant IR, Freercks RJ, Honiball EJ, Dube B. Analysis of the vascular access service for patients on haemodialysis in Livingstone Hospital. Cardiovasc J Afr. 2021;32(2):98\u2013101.","journal-title":"Cardiovasc J Afr"},{"issue":"18","key":"3593_CR41","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1001\/jama.2017.4046","volume":"317","author":"AK Bello","year":"2017","unstructured":"Bello AK, Levin A, Tonelli M, Okpechi IG, Feehally J, Harris D, et al. Assessment of global kidney health care status. JAMA. 2017;317(18):1864\u201381.","journal-title":"JAMA"},{"issue":"6","key":"3593_CR42","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1177\/11297298211011375","volume":"23","author":"R Ramachandran","year":"2022","unstructured":"Ramachandran R, Bhargava V, Jasuja S, Gallieni M, Jha V, Sahay M, et al. Interventional nephrology and vascular access practice: a perspective from South and Southeast Asia. J Vasc Access. 2022;23(6):849\u201360.","journal-title":"J Vasc Access"},{"issue":"2","key":"3593_CR43","doi-asserted-by":"publisher","first-page":"127","DOI":"10.4103\/1596-3519.112410","volume":"12","author":"SU Alhassan","year":"2013","unstructured":"Alhassan SU, Adamu B, Abdu A, Aji SA. Outcome and complications of permanent hemodialysis vascular access in nigerians: a single centre experience. Ann Afr Med. 2013;12(2):127\u201330.","journal-title":"Ann Afr Med"},{"issue":"5","key":"3593_CR44","doi-asserted-by":"publisher","first-page":"151338","DOI":"10.1016\/j.semnephrol.2023.151338","volume":"42","author":"EK Tannor","year":"2022","unstructured":"Tannor EK, Chika OU, Okpechi IG. The impact of low socioeconomic status on progression of chronic kidney disease in low- and lower Middle-Income Countries. Semin Nephrol. 2022;42(5):151338.","journal-title":"Semin Nephrol"},{"issue":"2","key":"3593_CR45","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4103\/ijn.IJN_55_19","volume":"29","author":"DC Crews","year":"2019","unstructured":"Crews DC, Bello AK, Saadi G, Li PKT, Garcia-Garcia G, Andreoli S, et al. Burden, Access, and disparities in kidney disease. Indian J Nephrol. 2019;29(2):77\u201383.","journal-title":"Indian J Nephrol"},{"key":"3593_CR46","doi-asserted-by":"crossref","unstructured":"Bello AK, Alrukhaimi M, Ashuntantang GE, Bellorin-Font E, Benghanem Gharbi M, Braam B et al. Global overview of health systems oversight and financing for kidney care. Kidney Int Suppl (2011). 2018;8(2):41\u201351.","DOI":"10.1016\/j.kisu.2017.10.008"},{"issue":"4","key":"3593_CR47","first-page":"e313","volume":"113","author":"L Mtingi-Nkonzombi","year":"2023","unstructured":"Mtingi-Nkonzombi L, Manning K, Du Toit T, Muller E, Redd AD, Freercks R. The state of kidney replacement therapy in Eastern Cape Province, South Africa: a call to action. S Afr Med J. 2023;113(4):e313.","journal-title":"S Afr Med J"},{"issue":"1","key":"3593_CR48","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1046\/j.1523-1755.2002.00426.x","volume":"62","author":"V Kher","year":"2002","unstructured":"Kher V. End-stage renal disease in developing countries. Kidney Int. 2002;62(1):350\u201362.","journal-title":"Kidney Int"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03593-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-024-03593-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03593-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T16:03:24Z","timestamp":1715184204000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-024-03593-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,8]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3593"],"URL":"https:\/\/doi.org\/10.1186\/s12882-024-03593-z","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,8]]},"assertion":[{"value":"22 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The University of Alberta Research Ethics Committee approved this project (Protocol number: PRO00063121). Informed consent was obtained from all respondents. Our study did not report experiments on humans and\/or the use of human tissue samples.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No individual person\u2019s data were used. Consent was not required by survey respondents.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have completed an ICMJE form. RK reports personal fees from Baxter healthcare, outside the submitted work. VAL reports royalties from Elsevier, consulting fees from the World Health Organization, travel support from the European Renal Association and International Society of Nephrology, and leadership role in Advocacy Working Group of the International Society of Nephrology, outside the submitted work. RRQ reports honoraria from Baxter Healthcare Corporation and the patent Dialysis Information Management System, Canada, outside the submitted work. NS reports personal fees from Baxter, grants and personal fees from Amgen, outside the submitted work. ST reports Fellowship grants from the International Society of Nephrology-Salmasi Family and the Kidney Foundation of Thailand, outside the submitted work. SA reports personal fees from The International Society of Nephrology, outside the submitted work. SD reports personal fees from The International Society of Nephrology, outside the submitted work. JD reports personal fees from The International Society of Nephrology, outside the submitted work. VJ reports personal fees from GSK, Astra Zeneca, Baxter Healthcare, Visterra, Biocryst, Chinook, Vera, and Bayer, paid to his institution, outside the submitted work. CM reports personal fees from The International Society of Nephrology, outside the submitted work. MN reports grants and personal fees from KyowaKirin, Boehringer Ingelheim, Chugai, Daiichi Sankyo, Torii, JT, Mitsubishi Tanabe, grants from Takeda and Bayer, and personal fees from Astellas, Akebia, AstraZeneca, and GSK, outside the submitted work. AKB reports other (consultancy and honoraria) from AMGEN Incorporated and Otsuka, other (consultancy) from Bayer and GSK, and grants from Canadian Institute of Health Research and Heart and Stroke Foundation of Canada, outside the submitted work; He is also Associate Editor of the Canadian Journal of Kidney Health and Disease and Co-chair of the ISN-Global Kidney Health Atlas. DWJ reports consultancy fees, research grants, speaker\u2019s honoraria and travel sponsorships from Baxter Healthcare and Fresenius Medical Care, consultancy fees from Astra Zeneca, Bayer, and AWAK, speaker\u2019s honoraria from ONO and Boehringer Ingelheim & Lilly, and travel sponsorships from Ono and Amgen, outside the submitted work. He is also a current recipient of an Australian National Health and Medical Research Council Leadership Investigator Grant, outside the submitted work. All other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"159"}}